$SCYX
SCYNEXIS INC

2024 Q4 Form 10-Q Financial Statement

#000095017024122241 Filed on November 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $660.0K
YoY Change -62.52%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $660.0K
YoY Change -52.86%
Gross Profit Margin 100.0%
Selling, General & Admin $2.907M
YoY Change -42.02%
% of Gross Profit 440.45%
Research & Development $8.073M
YoY Change 24.85%
% of Gross Profit 1223.18%
Depreciation & Amortization $0.00
YoY Change -100.0%
% of Gross Profit 0.0%
Operating Expenses $10.98M
YoY Change -7.41%
Operating Profit -$10.32M
YoY Change 2.2%
Interest Expense $366.0K
YoY Change 72.64%
% of Operating Profit
Other Income/Expense, Net $7.117M
YoY Change -14.67%
Pretax Income -$3.203M
YoY Change 82.3%
Income Tax -$395.0K
% Of Pretax Income
Net Earnings -$2.808M
YoY Change 59.82%
Net Earnings / Revenue -425.45%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$0.06
COMMON SHARES
Basic Shares Outstanding 37.95M 37.86M
Diluted Shares Outstanding 48.62M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.83M
YoY Change -21.88%
Cash & Equivalents $28.73M
Short-Term Investments $40.10M
Other Short-Term Assets $953.0K
YoY Change -49.71%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $80.46M
YoY Change -37.45%
LONG-TERM ASSETS
Property, Plant & Equipment $2.163M
YoY Change -9.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $16.12M
YoY Change -5.75%
Other Assets $296.0K
YoY Change 1084.0%
Total Long-Term Assets $18.58M
YoY Change -6.68%
TOTAL ASSETS
Total Short-Term Assets $80.46M
Total Long-Term Assets $18.58M
Total Assets $99.04M
YoY Change -33.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.955M
YoY Change 41.98%
Accrued Expenses $5.508M
YoY Change -42.28%
Deferred Revenue
YoY Change
Short-Term Debt $13.23M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.72M
YoY Change 53.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $14.79M
YoY Change -47.18%
Total Long-Term Liabilities $14.79M
YoY Change -62.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.72M
Total Long-Term Liabilities $14.79M
Total Liabilities $40.51M
YoY Change -28.37%
SHAREHOLDERS EQUITY
Retained Earnings -$372.1M
YoY Change 10.84%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.53M
YoY Change
Total Liabilities & Shareholders Equity $99.04M
YoY Change -33.33%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$2.808M
YoY Change 59.82%
Depreciation, Depletion And Amortization $0.00
YoY Change -100.0%
Cash From Operating Activities $765.0K
YoY Change -93.84%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.941M
YoY Change -107.37%
Cash From Investing Activities $1.941M
YoY Change -107.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 31.00K
YoY Change 3.33%
NET CHANGE
Cash From Operating Activities 765.0K
Cash From Investing Activities 1.941M
Cash From Financing Activities 31.00K
Net Change In Cash 2.737M
YoY Change -119.68%
FREE CASH FLOW
Cash From Operating Activities $765.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001178253
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36365
dei Entity Registrant Name
EntityRegistrantName
SCYNEXIS, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2181648
dei Entity Address Address Line1
EntityAddressAddressLine1
1 Evertrust Plaza
dei Entity Address Address Line2
EntityAddressAddressLine2
13th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Jersey City
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07302-6548
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
884-5485
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
SCYX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37948991
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28730000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34050000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
40098000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
40312000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1538000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5548000
CY2024Q3 scyx License Agreement Receivable
LicenseAgreementReceivable
153000
CY2023Q4 scyx License Agreement Receivable
LicenseAgreementReceivable
2463000
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
9509000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
19363000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
435000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
380000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
80463000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
102116000
CY2024Q3 us-gaap Investments
Investments
16116000
CY2023Q4 us-gaap Investments
Investments
23594000
CY2024Q3 us-gaap Deferred Costs
DeferredCosts
187000
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
175000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
109000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
163000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2163000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2364000
CY2024Q3 us-gaap Assets
Assets
99038000
CY2023Q4 us-gaap Assets
Assets
128412000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4955000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7149000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5508000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7495000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1642000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1189000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
389000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
340000
CY2024Q3 scyx Warrant Liabilities Current
WarrantLiabilitiesCurrent
0
CY2023Q4 scyx Warrant Liabilities Current
WarrantLiabilitiesCurrent
130000
CY2024Q3 scyx Convertible Debt And Derivative Liability Current
ConvertibleDebtAndDerivativeLiabilityCurrent
13225000
CY2023Q4 scyx Convertible Debt And Derivative Liability Current
ConvertibleDebtAndDerivativeLiabilityCurrent
0
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
25719000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16303000
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1294000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2727000
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
11212000
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
21680000
CY2024Q3 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
0
CY2023Q4 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
12159000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2284000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2581000
CY2024Q3 us-gaap Liabilities
Liabilities
40509000
CY2023Q4 us-gaap Liabilities
Liabilities
55450000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37943241
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37943241
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37207799
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37207799
CY2024Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
41000
CY2023Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
40000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
430590000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
428169000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-372102000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-355247000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
58529000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
72962000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
99038000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128412000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
660000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1761000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2769000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
134344000
CY2024Q3 scyx Cost Of Product Revenues
CostOfProductRevenues
0
CY2023Q3 scyx Cost Of Product Revenues
CostOfProductRevenues
379000
scyx Cost Of Product Revenues
CostOfProductRevenues
0
scyx Cost Of Product Revenues
CostOfProductRevenues
940000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8073000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6466000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22091000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20342000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2907000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5014000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9742000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17328000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
10980000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
11859000
us-gaap Operating Expenses
OperatingExpenses
31833000
us-gaap Operating Expenses
OperatingExpenses
38610000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10320000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10098000
us-gaap Operating Income Loss
OperatingIncomeLoss
-29064000
us-gaap Operating Income Loss
OperatingIncomeLoss
95734000
CY2024Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
441000
CY2023Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
360000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1262000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2616000
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
1020000
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
1263000
us-gaap Interest Income Other
InterestIncomeOther
3422000
us-gaap Interest Income Other
InterestIncomeOther
2590000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
213000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
212000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
617000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2908000
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6751000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7468000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10598000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5991000
CY2024Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
182000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
196000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-182000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7117000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8341000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12337000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9107000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3203000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1757000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16727000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
86627000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-395000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
128000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2808000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1757000
us-gaap Net Income Loss
NetIncomeLoss
-16855000
us-gaap Net Income Loss
NetIncomeLoss
86627000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.81
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.78
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48618693
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47891996
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48459777
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47829614
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48618693
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47891996
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48459777
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49397273
us-gaap Profit Loss
ProfitLoss
-16855000
us-gaap Profit Loss
ProfitLoss
86627000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0
us-gaap Depreciation And Amortization
DepreciationAndAmortization
451000
us-gaap Share Based Compensation
ShareBasedCompensation
2365000
us-gaap Share Based Compensation
ShareBasedCompensation
2067000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1097000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
702000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1262000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2616000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10598000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5991000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
196000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-182000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
201000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
169000
scyx Write Off Of Deferred Asset For Commitment Fees
WriteOffOfDeferredAssetForCommitmentFees
0
scyx Write Off Of Deferred Asset For Commitment Fees
WriteOffOfDeferredAssetForCommitmentFees
514000
scyx Prepayment Fee For Loan Payable Payment
PrepaymentFeeForLoanPayablePayment
0
scyx Prepayment Fee For Loan Payable Payment
PrepaymentFeeForLoanPayablePayment
263000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-4032000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
668000
scyx Increase Decrease In License Agreement Receivable
IncreaseDecreaseInLicenseAgreementReceivable
-2310000
scyx Increase Decrease In License Agreement Receivable
IncreaseDecreaseInLicenseAgreementReceivable
2349000
scyx Increase Decrease In License Agreement Contract Asset
IncreaseDecreaseInLicenseAgreementContractAsset
-9854000
scyx Increase Decrease In License Agreement Contract Asset
IncreaseDecreaseInLicenseAgreementContractAsset
19309000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
144000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7387000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2166000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2447000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1987000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3915000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-979000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4081000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-248000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-5976000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14102000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
67894000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
27985000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
73275000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
36752000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
40550000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8767000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32725000
scyx Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
40000
scyx Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
0
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
36383000
scyx Payment Of Loan Payable Prepayment Fee
PaymentOfLoanPayablePrepaymentFee
0
scyx Payment Of Loan Payable Prepayment Fee
PaymentOfLoanPayablePrepaymentFee
263000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
56000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
42000
scyx Payments For Proceeds From Repurchase Of Shares To Satisfy Tax Withholdings
PaymentsForProceedsFromRepurchaseOfSharesToSatisfyTaxWithholdings
0
scyx Payments For Proceeds From Repurchase Of Shares To Satisfy Tax Withholdings
PaymentsForProceedsFromRepurchaseOfSharesToSatisfyTaxWithholdings
-18000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-36586000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5319000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1417000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34593000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46032000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29274000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44615000
us-gaap Interest Paid Net
InterestPaidNet
840000
us-gaap Interest Paid Net
InterestPaidNet
3248000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
2623000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
2644000
scyx Deferred Offering Costs Included In Accounts Payable
DeferredOfferingCostsIncludedInAccountsPayable
12000
scyx Deferred Offering Costs Included In Accounts Payable
DeferredOfferingCostsIncludedInAccountsPayable
0
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-372100000
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
84900000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2808000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1757000
us-gaap Net Income Loss
NetIncomeLoss
-16855000
us-gaap Net Income Loss
NetIncomeLoss
86627000
CY2024Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
CY2023Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
1437000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2808000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1757000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-16855000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
88064000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48618693
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47891996
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48459777
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47829614
CY2024Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2023Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1138200
CY2024Q3 scyx Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0
CY2023Q3 scyx Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0
scyx Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0
scyx Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
429459
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48618693
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47891996
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48459777
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49397273
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.78
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22450442
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27202392
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22450442
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24409222
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassification of Prior Year Amounts</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain prior year amounts within the changes in operating assets and liabilities on the unaudited condensed consolidated statement of cash flows and certain prior year accrued expenses have been reclassified for consistency with the current year presentation.</span></p>
CY2024Q3 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
0
CY2023Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
196000
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
427000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
264000
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
158000
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
182000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
953000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4906000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1538000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5548000
CY2024Q3 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
1866000
CY2023Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
2830000
CY2024Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1337000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1692000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
969000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1040000
CY2024Q3 scyx Accrued Product Recall
AccruedProductRecall
1336000
CY2023Q4 scyx Accrued Product Recall
AccruedProductRecall
1933000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5508000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7495000
scyx Amortization Of Remaining Financing Costs And Discounts
AmortizationOfRemainingFinancingCostsAndDiscounts
2000000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has the option to renew for two consecutive five-year periods from the end of the first term and the Company is not reasonably certain that the option to renew the Lease will be exercised. Under the Lease, the Company furnished a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which was reduced by fifty-five thousand dollars on the first anniversary of the commencement date. The security deposit will continue to be reduced by fifty-five thousand dollars every two years on the commencement date anniversary for eight years.
CY2018Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
166000
us-gaap Operating Lease Cost
OperatingLeaseCost
498000
us-gaap Operating Lease Cost
OperatingLeaseCost
498000
CY2024Q3 scyx Variable Lease Cost Credit
VariableLeaseCostCredit
28000
CY2023Q3 scyx Variable Lease Cost Credit
VariableLeaseCostCredit
44000
scyx Variable Lease Cost Credit
VariableLeaseCostCredit
32000
scyx Variable Lease Cost Credit
VariableLeaseCostCredit
148000
CY2024Q3 us-gaap Lease Cost
LeaseCost
194000
CY2023Q3 us-gaap Lease Cost
LeaseCost
210000
us-gaap Lease Cost
LeaseCost
530000
us-gaap Lease Cost
LeaseCost
646000
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
183000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
180000
us-gaap Operating Lease Payments
OperatingLeasePayments
545000
us-gaap Operating Lease Payments
OperatingLeasePayments
534000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M2D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M2D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
185000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
744000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
759000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
774000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
790000
CY2024Q3 scyx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
466000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3718000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2673000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
389000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2284000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2673000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1045000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37943241
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37207799
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
60406000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2808000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
900000
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
31000
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
58529000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
93078000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1757000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
632000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
38000
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
91991000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
72962000
us-gaap Net Income Loss
NetIncomeLoss
-16855000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2365000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
56000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
58529000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3233000
us-gaap Net Income Loss
NetIncomeLoss
86627000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2067000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
42000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
18000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
91991000
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
41074070
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
40613284
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6800000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7500000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10600000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6000000
CY2024Q3 scyx Fair Value Of Liabilities
FairValueOfLiabilities
11200000
CY2023Q4 scyx Fair Value Of Liabilities
FairValueOfLiabilities
21800000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1867795
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.72
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
184000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1070060
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
25548
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
36.35
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2912307
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.23
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1649450
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
11.2
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y2M1D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2912307
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.23
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y10M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2100000
CY2024Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2023Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
901000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
632000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2365000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2067000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2057000
scyx Contract With Customer Liability Provision Related To Current Period Revenue
ContractWithCustomerLiabilityProvisionRelatedToCurrentPeriodRevenue
0
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
25000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-648000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1434000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1541000
scyx Contract With Customer Liability Provision Related To Current Period Revenue
ContractWithCustomerLiabilityProvisionRelatedToCurrentPeriodRevenue
7062000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-51000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3807000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4745000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1600000
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1300000

Files In Submission

Name View Source Status
0000950170-24-122241-index-headers.html Edgar Link pending
0000950170-24-122241-index.html Edgar Link pending
0000950170-24-122241.txt Edgar Link pending
0000950170-24-122241-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-20240930.htm Edgar Link pending
scyx-20240930.xsd Edgar Link pending
scyx-ex31_1.htm Edgar Link pending
scyx-ex31_2.htm Edgar Link pending
scyx-ex32_1.htm Edgar Link pending
Show.js Edgar Link pending
scyx-20240930_htm.xml Edgar Link completed